Qure.ai Technologies
Qure.ai — mission
Qure.ai was founded in 2016 with the mission to use artificial intelligence to make healthcare more accessible and affordable. The company builds AI-powered medical imaging solutions that support clinicians, public-health programs and life-sciences partners to accelerate diagnosis, triage and treatment decisions.
What we do
Qure.ai develops FDA-cleared and WHO-evaluated products for chest X‑ray reporting, TB screening, lung nodule management, stroke/TBI triage and other clinical pathways. Key offerings include qXR (chest X‑ray AI), qTrack (screening and case‑management platform), qER (stroke & TBI) and related solutions for MSK and heart failure. Qure.ai reports global impact metrics on its site: 45M+ lives impacted, deployment across 105+ countries and 5,500+ sites, and training datasets exceeding 1B images. The company partners with healthcare providers, governments and industry leaders to scale AI in real‑world clinical and screening programs.
